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Background: Magnetic hyperthermia is currently a clinical therapy approved in the European 
Union for treatment of tumor cells, and uses magnetic nanoparticles (MNPs) under time-varying 
magnetic fields (TVMFs). The same basic principle seems promising against trypanosomatids 
causing Chagas disease and sleeping sickness, given that the therapeutic drugs available have 
severe side effects and that there are drug-resistant strains. However, no applications of this strat-
egy against protozoan-induced diseases have been reported so far. In the present study, Crithidia 
fasciculata, a widely used model for therapeutic strategies against pathogenic trypanosomatids, 
was targeted with Fe
3
O
4
 MNPs in order to provoke cell death remotely using TVMFs.
Methods: Iron oxide MNPs with average diameters of approximately 30 nm were synthesized 
by precipitation of FeSO
4
 in basic medium. The MNPs were added to C. fasciculata choano-
mastigotes in the exponential phase and incubated overnight, removing excess MNPs using 
a DEAE-cellulose resin column. The amount of MNPs uploaded per cell was determined by 
magnetic measurement. The cells bearing MNPs were submitted to TVMFs using a homemade 
AC field applicator (f = 249 kHz, H = 13 kA/m), and the temperature variation during the 
experiments was measured. Scanning electron microscopy was used to assess morphological 
changes after the TVMF experiments. Cell viability was analyzed using an MTT colorimetric 
assay and flow cytometry.
Results: MNPs were incorporated into the cells, with no noticeable cytotoxicity. When a 
TVMF was applied to cells bearing MNPs, massive cell death was induced via a nonapoptotic 
mechanism. No effects were observed by applying TVMF to control cells not loaded with 
MNPs. No macroscopic rise in temperature was observed in the extracellular medium during 
the experiments.
Conclusion: As a proof of principle, these data indicate that intracellular hyperthermia is a 
suitable technology to induce death of protozoan parasites bearing MNPs. These findings expand 
the possibilities for new therapeutic strategies combating parasitic infection.
Keywords: magnetic hyperthermia, magnetic nanoparticles, trypanosomatids, Crithidia 
fasciculata
Introduction
Diseases caused by the Trypanosoma and Leishmania genera affect a global population 
of at least 20 million people, with an estimated at-risk population of approximately 
450 million people.1,2 These statistics indicate that trypanosomatid-induced diseases 
are a severe sanitary problem, with the resulting disease burden affecting much of the 
population residing in the tropical and subtropical regions of the globe.3,4 Despite the 
sanitary relevance of trypanosomatid-induced diseases to human health, no satisfactory 
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treatments exist to combat these infections.5–7 The two 
therapeutic agents that are presently in use for the treatment 
of Chagas disease are nifurtimox and benzimidazole; how-
ever, these drugs were developed approximately 40 years 
ago.8 The main disadvantages of these treatments are a high 
level of toxicity and low therapeutic efficiency during the 
chronic phase of the disease. The latter disadvantage is a 
serious problem because Chagas disease is often diagnosed 
during the chronic phase; therefore, the majority of infected 
people miss the opportunity to be treated using effective 
chemotherapy.9 In addition, several cases of drug-resistant 
or partially resistant strains have been reported for both of 
these drugs.10
The initial stages of Trypanosoma brucei infections, when 
the central nervous system is not compromised, can be treated 
using suramin or pentamidine.11 Again, these drugs are not 
effective during the late stages of the disease (when the major-
ity of cases are diagnosed) because they do not traverse the 
blood–brain barrier. The first-line treatment for these cases 
is melarsoprol, which can cross the blood–brain barrier. 
Melarsoprol is a highly toxic drug that causes a myriad of 
serious side effects, including reactive encephalopathy, in 
approximately 20% of patients receiving this treatment.12 
For the treatment of diseases caused by Leishmania spp., 
pentavalent antimonials are used most often.13 Although 
these drugs are effective for treating the cutaneous form of 
the disease, treatments for the parenteral form are limited. 
In addition, these drugs are highly toxic.
Amphotericin B and pentamidine are considered to be 
second-line drugs because of their serious and/or irrevers-
ible toxic effects. However, these drugs are now being 
reconsidered on the basis of new formulations or dosage 
regimens.13–15 The fact that the majority of drugs currently 
used for trypanosomatid-induced diseases were developed 
approximately 40 years ago reflects the limited success of 
strategies to develop novel therapeutic treatments. This lack 
of success highlights the necessity for new strategies and 
tools to address this important public health issue.
Magnetic hyperthermia is a relatively new medical 
protocol16 that uses magnetic nanoparticles (MNPs) to heat 
areas of the body by application of time-varying magnetic 
fields (TVMFs). The physical mechanisms underlying 
energy absorption by MNPs are related to magnetic relax-
ation of single domains by Arrhenius-Néel processes.4,17 
With the advent of nanotechnology, it has become possible 
to engineer efficient MNPs with the ability to absorb large 
amounts of energy from TVMFs (up to several kW per 
gram of material) to induce a local rise in temperature.18 
Because of their size, these nanoparticles can be incorpo-
rated into target cells, making it possible to heat small foci 
at the single cell level.19 Application of hyperthermia using 
MNPs, alone or in combination with other therapeutic strat-
egies, was proposed more than a decade ago as a therapeutic 
technique to treat cancer.16 In the present study, we used 
Crithidia fasciculata, a nonpathogenic trypanosomatid and 
a well accepted model of other pathogenic trypanosomatid 
parasites,20 to evaluate the use of magnetic hyperthermia 
as a potential trypanocidal treatment. The mechanisms of 
cell death and application of the principles of magnetic 
hyperthermia to treat parasitic diseases are discussed in 
later sections of this paper.
Materials and methods
Reagents and culture media
The chemicals and fetal calf serum used for the present 
study were purchased from Sigma (St Louis, MO). The 
other components of the culture medium were purchased 
from Difco (Lawrence, KS). The apoptosis detection kit 
was purchased from Immunostep (Coimbra, Portugal). The 
diethylaminoethyl (DEAE) cellulose (DE52) was purchased 
from Whatman (Dassel, Germany).
Cells
C. fasciculata choanomastigotes were grown at 28°C in 
Warren culture medium (brain heart infusion 37 g/L, hemin 
100 ng/L, folic acid 100 mg/L) supplemented with 10% 
fetal calf serum. The cells were seeded in 75 cm3 tissue 
culture plates at 1 × 106 cells/mL. C. fasciculata cultures 
were incubated until they reached the exponential phase 
(after approximately 24 hours of incubation). Using daily 
subculturing, the cells were maintained in the exponential 
growth phase for use in the studies. Cell counting was 
performed in a Neubauer chamber. The cells were evalu-
ated for viability by optical microscopic observation of 
flagellar motility and by counting the number of viable 
cells after incubation with 2% Trypan blue in phosphate-
buffered solution.
Magnetic nanoparticles
The MNPs used in the present study were synthesized using 
precipitation of iron (II) salt (FeSO
4
) in the presence of a base 
(NaOH) and a mild oxidant (KNO
3
) under a nitrogen atmo-
sphere, as previously described in the literature.21 Mixing the 
reactants over a 24-hour period resulted in Fe
3
O
4
 particles 
with average diameters of about 30 nm and colloidal stability 
in aqueous medium at pH 7.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
5352
Grazú et al
International Journal of Nanomedicine 2012:7
Cell uptake of MNPs and separation  
of nonincorporated MNPs
The cells collected during the exponential growth phase 
were centrifuged and resuspended in fresh culture medium, 
adjusting concentrations to 2.5 × 108 cells/mL. The MNPs 
were added to a final concentration of 0.425 mg/mL and 
incubated at 28°C overnight with gentle agitation. To 
separate the cells from the nonincorporated MNPs, we took 
advantage of the fact that MNPs (isoelectric point 5.0) adsorb 
to DEAE-cellulose resin at pH 7.0 (isoelectric point 2.5), 
whereas C. fasciculata does not interact with the resin under 
these conditions. Briefly, the cells were washed twice with 
phosphate-buffered solution, resuspended in 12 mL of 2% 
glucose in phosphate-buffered solution, and incubated with 
6 g DEAE-cellulose ionic exchange resin that was previously 
equilibrated with glucose in phosphate-buffered solution for 
10 minutes with gentle agitation at room temperature. The 
cells were recovered with an efficiency of more than 95%.
Determination of cell-incorporated 
MNPs by magnetization measurements
The amounts of cell-associated MNPs were determined by 
measuring the saturation magnetization using a supercon-
ducting quantum interference device (MPMS-7T, Quantum 
Design, San Diego, CA). The magnetization measurements 
were conducted on dried MNPs or lyophilized MNP-loaded 
cells, and were performed as a function of the applied mag-
netic field up to 5 kOe (0.4 MA/m) at different temperatures 
between 5 K and 300 K.
Time-varying magnetic field  
application experiments
Aliquots of MNPs (10 mg/mL) or MNP-bearing cells 
(1.7 × 109 cells/mL) were submitted to alternating magnetic 
fields using a homemade AC field applicator. The magnetic 
field applicator, consisting of a resonant LC tank working 
close to the resonant frequency, was used to measure the 
specific power absorption of the samples. A magnetic field 
(f = 249 kHz, H = 13 kA/m) was achieved inside a gap of 
four (2 + 2) turns of a copper tube around high permeability 
polar pieces. The specific power absorption values were 
obtained from adiabatic measurements inside an insulated 
Dewar flask. The temperature data were measured using a 
fiberoptic temperature probe (ReflexTM, Neoptix, Fairport, 
NY) that was immune to the radiofrequency environment. 
Prior to each experiment, temperature evolution was mea-
sured between the 5-minute and 10-minute time points, with 
the RF source turned off to establish a temperature baseline. 
Next, the power was turned on, and the temperature rise was 
monitored for a 30-minute period.
Scanning electron microscopy
Cells in the exponential growth phase were fixed with 2.5% 
glutaraldehyde in 0.1 M sodium cacodylate and 3% sucrose 
solution for 90 minutes at 4°C. The dehydration process was 
conducted by incubating the cells in increasing concentra-
tions of methanol at 30%, 50%, 70%, and 100%. Each of 
these concentrations were used for 5 minutes in duplicate, 
and a final step was conducted using anhydride methanol 
for 10 minutes. A drop of the dehydrated cells in suspension 
was placed over a coverslip. Next, when the methanol was 
evaporated, the coverslip was coated with gold. The samples 
were then observed using scanning electron microscopy 
(EDX Hitachi S-3400 N, Instituto Carboquimica, Zaragoza, 
Spain). Secondary electron images were also performed.
Viability analysis
MTT assay
Cell viability was analyzed using the MTT colorimetric assay. 
For the cytotoxicity assay, 5 × 106 cells (MNPs-/TVMF-, 
MNPs-/TVMF+, MNPs+/TVMF-, or MNPs+/TVMF+) were 
resuspended in 100 µL of Warren culture medium. Next, 
40 µL of MTT dye solution (5 mg/mL in glucose in phosphate-
buffered solution) was added to each aliquot. After 4 hours of 
incubation in Eppendorf tubes at 28°C, the formazan crystals 
were dissolved by addition of 10% sodium dodecyl sulfate 
100 µL. All of the cell debris, which has been shown to inter-
fere with the assay, was removed by centrifugation (10 minutes 
at 13,000 × g ). Next, absorbance of each supernatant was 
read using a microplate reader (Biotek ELX800, Winooski, 
VT) at 570 nm. The spectrophotometer was calibrated to 
zero absorbance using a culture medium without cells. The 
relative cell viability (%) compared with the control cells (the 
exponential-phase cells not submitted to any treatment) was 
calculated as [absorbance] test/[absorbance] control × 100. 
Each measurement was repeated at least five times to obtain 
mean values with standard deviations.
Flow cytometry
The cell viability was also measured using flow cytometry 
with a commercial apoptosis detection kit purchased from 
Immunostep. Briefly, 1 × 106 cells from each sample were 
resuspended in annexin-binding buffer, stained with 5 µL 
of annexin and 5 µL of propidium iodide, and incubated for 
15 minutes at room temperature in the dark. The cell analysis 
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was performed using the FACSAria cytometer (Becton Dick-
inson, Franklin Lakes, NJ) and FACSDiva software.
Results and discussion
The magnetic and physicochemical properties of the MNPs 
used in the present study have been reported elsewhere.22 
The magnetic colloids were composed of cubic Fe
3
O
4
 
nanoparticles with an average diameter of 30 ± 8 nm and 
saturation magnetization at room temperature of 85 emu/g, 
which is close to that of the bulk magnetite magnetization.23 
This synthesis route resulted in magnetic colloids with an 
isoelectric point of 5.0, electrostatically stabilized due to 
adsorption of SO
4
2- groups on the particle surface. The abil-
ity to dissipate heat under a TVMF of any type of MNP is 
measured by the specific power absorption given in watts 
per gram of magnetic material, which for the present MNPs 
and experimental conditions (f = 249 kHz, H = 13 kA/m) 
was found to be 83.6 W/g,22 comparable with other specific 
power absorption values reported in the literature for Fe
3
O
4
 
particles of similar size.24–26 The selection of MNPs was made 
based on the known dependence of specific power absorp-
tion values on an average particle size and size distribution. 
Indeed, the strong dependence of the Nèel relaxation-based 
model on particle size yields a maximum value of specific 
power absorption for magnetite MNPs within a narrow range 
of diameters around 15–30 nm,4 as experimentally confirmed 
in many colloidal system yields.3,19,21 The precise value for 
this maximum will depend on other magnetic properties 
of the MNPs, such as magnetic anisotropy and saturation 
magnetization.
The optimal experimental conditions for C. fasciculata 
to incorporate MNPs were determined by a series of 
experiments as a function of incubation time, incubating 
C. fasciculata with a fixed MNP concentration for increasing 
times from 15 to 240 minutes. After incubation, the nonin-
corporated MNPs were separated by the column method 
detailed in the Materials and Methods section. The mass 
of magnetic material incorporated per cell was determined 
by measuring the saturation magnetization of 100 µL of 
culture medium containing about 109 cells and comparing 
these values with the magnetization of pure colloid.27 From 
these data and the average particle size, the average number 
of MNPs incorporated per cell was calculated (Table 1). The 
number of MNPs incorporated decreased from a maximum 
of approximately 108 nanoparticles per cell after 15 minutes 
of incubation to approximately 106 nanoparticles per cell 
after 1 hour of incubation. Shorter incubation times resulted 
in low and highly variable cell charging, possibly due to 
the fact that the cells require an induction time to activate 
biological mechanisms to incorporate the MNPs. The time 
course of this decrease in cell-associated MNPs followed an 
exponential decay (R2 0.9998), reaching a near-steady state 
after approximately 1 hour of incubation, which remained 
essentially constant for up to 12 hours of incubation (Figure 1 
and Figure S1). From these experiments, we established 
15 minutes of incubation as being the optimal condition for 
charging the cells with a reproducible and defined number 
of MNPs per cell.
To evaluate the suitability of MNPs for hyperthermic 
applications, it was necessary to assess the influence of 
these nanoparticles on cell viability and on incorporation and 
separation conditions. It was observed that, when compared 
with cells in the exponential phase, the nanoparticle-treated 
or mock-treated cultures submitted to separation condi-
tions (incubated with DEAE-cellulose resin in glucose in 
phosphate-buffered solution) remained more than 95% viable 
(data not shown). This finding illustrates that the cell death 
observed in subsequent experiments was not due to previous 
exposure of the cells to toxic conditions.
hyperthermia experiments
After the best conditions for maximum uptake of MNPs by 
the cells were determined (15 minutes of incubation, as stated 
above), the hyperthermia experiments were performed. The 
experiments were designed in a 2 × 2 row-column format 
(Figure 2), in which the four groups were defined as follows: 
cells not-bearing MNPs that were not submitted to TVMFs 
(MNPs-/TVMF-); cells bearing MNPs that were not submit-
ted to magnetic field application (MNPs+/TVMF-); cells not 
bearing MNPs that were submitted to magnetic field appli-
cation (MNPs-/TVMF+); and cells bearing MNPs that were 
submitted to magnetic field application (MNPs+/TVMF+). 
Table 1 Average number of magnetic nanoparticles incorporated within a single cell as a function of incubation time, as calculated from 
the saturation magnetization of magnetically loaded cells
Time 15 minutes 30 minutes 45 minutes 1 hour 1.5 hours 2 hours 4 hours 12 hours
Mass of Fe3O4 (pg/cell) 12.3 0.55 0.31 0.14 0.22 0.15 0.23 0.18
Number of MNPs (×106)/cell 87 3.9 2.2 1.0 1.6 1.1 1.6 1.3
Abbreviation: MNPs, magnetic nanoparticles.
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The effects of the abovementioned treatments on cell 
viability were evaluated using several criteria, including 
direct observation of cell motility using optical micro-
scopic observation, mitochondrial activity using an MTT 
assay, and detailed morphology using scanning electronic 
microscopy (SEM). Qualitative observation of the samples 
examined using the previously described treatments showed 
that the MNPs+/TVMF+ population caused 100% cell death 
(see Supplementary materials). Quantitative analysis of the 
cells by MTT assay revealed that the cell viability of all 
of the other samples was not affected compared with the 
control (MNPs-/TVMF-, Figure 3). Analysis of all four 
samples using SEM revealed severe structural damage in 
cell morphology only for the MNPs+/TVMF+ population, 
particularly at the level of the cell surface, indicating severe 
plasma membrane damage (Figure 4).
Cell death
Because application of the TVMFs was performed in 
an adiabatic device, hyperthermia treatment could have 
produced a transient macroscopic increase in the sample 
temperature due to differences in rates of heat generation 
and dissipation. When a positive control experiment was 
conducted by applying a TVMF to a suspension contain-
ing only MNPs (Figure 5), the sample showed a large 
increase in temperature of about 50°C over the 30 minutes 
of the experiment. Therefore, we tested whether a similar 
increase in average temperature might have contributed to 
the amount of cell death by monitoring the temperature of 
the extracellular medium during application of TVMF. The 
results for both the controls and magnetically loaded cells 
showed only a slight macroscopic increase in temperature 
(about 2°C–4°C) after 30 minutes of TVMF application. 
This result (ie, an absence of temperature increase in samples 
composed of magnetically loaded cells) is expected, based 
on the much lower “average concentration” of MNPs in these 
samples, because the small amounts of uploaded MNPs are 
contained within a total volume of about 0.5 mL of liquid 
cell medium.
These results clearly demonstrate that the heat released 
from the MNPs was not enough to increase the average 
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Figure 1 Number of magnetic nanoparticles uploaded per cell as a function of 
incubation time. 
Notes: The observed decrease of incorporated magnetic nanoparticles followed 
an exponential decay, and reached a near-steady state for incubation times longer 
than 1 hour. 
Abbreviation: NP, nanoparticles.
Figure 2 Schematic view of the experimental 2 × 2 design for evaluating the effect 
of magnetic nanoparticles and time-varying magnetic fields on Crithidia fasciculata. 
(A) Cells without magnetic nanoparticles not submitted to magnetic fields. (B) Cells 
with magnetic nanoparticles without magnetic field application. (C) Application of 
magnetic fields on unloaded cells. (D) Application of magnetic fields on magnetic 
nanoparticle-loaded cells.
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Figure 3 MTT assay results for the four conditions displayed in Figure 2. 
Notes: All samples showed 100% of cell viability except in the case of time-varying 
magnetic fields applied on magnetically loaded cells, which caused 95% ± 5% cell death.
Abbreviations: MNPs-/TVMF-, cells not-bearing MNPs that were not submitted to 
TVMF; MNPs+/TVMF-, cells bearing MNPs that were not submitted to magnetic field 
application; MNPs-/TVMF+, cells not bearing MNPs that were submitted to magnetic 
field application; MNPs+/TVMF+, cells bearing MNPs that were submitted to magnetic 
field application; MNPs, magnetic nanoparticles; TVMF, time-varying magnetic field; 
MTT, (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
5355
Magnetic hyperthermia as a potential trypanocidal therapy
International Journal of Nanomedicine 2012:7
temperature of the cell culture in such a way that would 
compromise viability of the cells. Therefore, the origin of 
cell death measured after application of TVMF should not 
be related to thermal stress. This is in agreement with previ-
ous works on magnetically loaded human dendritic cells,19,28 
demonstrating that application of TVMF for 30 minutes 
yielded up to 90%–95% cell death, without affecting blank 
cells without MNPs. Similar results have been reported in an 
HeLa cell line29 loaded with MNPs. Some theoretical models 
of metal nanoparticles have also suggested this possibility.30 
Because the temperature was essentially constant during the 
experiments, the cell death observed suggests an intracellu-
lar MNP-triggered mechanism different from the apoptosis 
induced by hyperthermia. However, because the temperature 
was measured with a macroscopic sensor, the possibility of 
intracellular heating up to apoptotic temperatures cannot be 
excluded.
To evaluate the plausibility of intracellular heating dur-
ing our experiments, a simplified heat transfer model at the 
single-cell level was considered, eg, a single cell magnetically 
loaded with MNPs, surrounded by a large matrix of unloaded 
cells (or culture medium free of MNPs). We estimated the 
expected intracellular temperature increase in such a case 
based on the measured mass of MNPs in the intracellular 
medium, the calculated average cell volume from SEM 
images (230 ± 50 µm3), and the measured specific power 
absorption values of the pure magnetic colloid. For simplic-
ity, we further approximated the specific heat capacity of a 
single cell to the pure water value of C
P
 = 4.18 J/(g · K). From 
the average cell volume and MNP upload (1–10 pg/cell), we 
estimated a temperature increase rate of 0.02–0.87 K/sec. The 
above calculations were made considering that no heat was 
dissipated from the intracellular medium to the cell environ-
ment, which was a clearly unrealistic hypothesis. Because 
the cell membrane has non-negligible thermal conductivity, 
the calculated heating rates were not enough to increase the 
intracellular temperature up to the 41°C–45°C needed for 
triggering thermally induced apoptotic mechanisms.
Several prior studies suggest that apoptosis-related 
mechanisms are a main cause of hyperthermia-associated cell 
death.19,31 Apoptosis (cellular programmed death) is a precise 
mechanism in which cells follow a programmed sequence of 
events to induce their death, with minimal disturbance to the 
total cell population.32 This phenomenon appears to be pres-
ent in a wide range of organisms, from primitive single-cell 
to higher multicellular eukaryotes. In the present work, we 
investigated whether the cell death of C. fasciculata induced 
by magnetic hyperthermia was attributable to apoptosis. An 
early event considered to be a marker of apoptosis is the 
appearance of phosphatidylserine on the external surface of 
the plasma membrane. Cells that incorporated nanoparticles 
and controls that were either submitted or not submitted to 
the magnetic field were incubated with annexin (used to 
detect the presence of phosphatidylserine) and propidium 
iodide (used to detect damage to the plasma membrane). 
Next, the four populations of cells were analyzed using flow 
cytometry. As illustrated in Figure 6, the results confirm 
100% viability for MNPs-/TVMF-, MNPs+/TVMF-, and 
MNPs-/TVMF+ cell samples and 0% viability of MNPs+/
TVMF+ cells. In this last case, it was observed that the cells 
were reactive to annexin and permeable to propidium iodide, 
indicating plasma membrane damage, which was confirmed 
using SEM (Figure 4). These results suggest that application 
Figure 4 Scanning electron microscopy images of MNPs+ (magnetic nanoparticles)/
TVMF+ (time-varying magnetic field) sample before (A) and after (B) application of 
magnetic fields. 
Note: In the latter case, the changes in cell morphology can be clearly observed, 
reflecting the severe cell damage after TVMF. 
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Figure 5 Specific power absorption of magnetic colloid (solid squares) at 1% weight 
concentration, and the nanoparticle-loaded protozoa (solid line) during application 
of AC magnetic field (H = 160 Oe, f = 250 khz). 
Abbreviations: MAN, magnetic colloid; C. fasciculata, Crithidia fasciculata; 
T, temperature; t, time.
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of TVMF to cells incorporating MNPs results in cell death 
via a nonapoptotic mechanism. Recent work on application 
of TVMF in magnetically loaded cells showed that a large 
decrease in cell viability can be achieved without an actual 
temperature increase in the cell medium.29,33 Furthermore, 
it has been reported that, in the case of magnetically loaded 
dendritic cells, the percentage of cell death was proportional 
to the amount of MNPs taken up.34 Because the cell death 
observed in our work corresponds to the maximum amount 
of uploaded MNPs (ie, after 15 minutes of cocultivation), 
it is still to be determined whether a similar effect could be 
achieved with smaller amounts of uploaded MNPs.
Taken together, our results lead us to propose that, in 
this case, irreversible cell injury due to mechanical stress 
(evidenced by SEM) in MNPs+/TVMF+ cell samples is the 
main cause of death. Theoretical calculations on the effect of 
the power released by MNPs on the cell membrane supports 
this hypothesis.35 However, it is worth mentioning that other 
factors, such as liberation of toxic proteins into the cytoplasm 
due to disruption of membranes compartmentalizing them 
inside specific organelles like lysosomes, cannot be ruled out 
as simultaneous cause of cell injury and death.
Conclusion
In conclusion, the series of experiments reported here dem-
onstrated as a proof of principle that magnetically induced 
hyperthermia can cause death of micro-organisms. Our results 
also illustrate that hyperthermia is a thermal phenomenon at a 
subcellular level because no macroscopic increase of tempera-
ture was observed. We were able to show that hyperthermia 
was specific for cells incorporating MNPs and submitted to 
TVMF because neither the nanoparticles nor TVMF alone 
resulted in loss of viability. Lastly, cells submitted to the 
hyperthermia treatment were dramatically damaged at the 
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Figure 6 Flow cytometry results of the 2 × 2 experiments shown in Figure 2 (see text for details). Experiments (A–C) showed 89%–91% cell viability, whereas for 
experiment (D), application of magnetic fields for 30 minutes on magnetically charged cells resulted in only 9% cell survival. 
Abbreviations: P1-A, propidium iodide; FITC, fluorescein isothiocyanate.
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plasma membrane level. It should be stressed that although this 
methodology is being extensively investigated and is currently 
used for mammalian cells, to our knowledge, it is not currently 
being proposed to treat diseases caused by micro-organisms. 
The present study highlights this method as a potential and 
novel alternative to treat infections caused by micro-organisms. 
A major advantage of this method is that it causes selective 
physical damage to target cells. Therefore, the probability of 
emergence of resistant strains is small. More detailed studies 
are also being conducted to identify the mechanisms involved 
in cell death in greater detail. Developing delivery systems 
with the capability to direct MNPs specifically to infectious 
agents remains a challenge. These findings lead us to propose 
this method as a novel strategy for developing new therapeutics 
against pathogenic micro-organisms.
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Figure S1 Magnetic response at T = 10 K from (A) unloaded cells, (B) response from Crithidia fasciculata cocultured with MNPs (sample incubated for 15 minutes), 
(C) difference between loaded and unloaded cells (B - A), and (D) pure magnetic colloid. Note that for the pure colloid (D), the curve was divided by 1.35 × 104 to fit the 
same scale as the magnetic signal from loaded cells (C).
Notes: To calculate the amount of magnetic material mmag incorporated by the cells, the MS values from the pure colloids and from the magnetic nanoparticle-loaded cells 
were calculated as m Number of cells.mag [g/cell] M/MS= ×  The number of magnetic nanoparticles per single cell was estimated from the known average particle diameter.
Supplementary materials
• File "a.mov": Cells without magnetic nanoparticles not submitted to magnetic fields
• File "b.mov": Cells with magnetic nanoparticles without magnetic field application
• File "c.mov":  Application of magnetic fields on unloaded cells
• File "d.mov":  Application of magnetic fields on magnetic nanoparticle-loaded cells
The 2 × 2 design for evaluating the effect of magnetic nanoparticles 
and time-varying magnetic fields on Crithidia fasciculata
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